289 related articles for article (PubMed ID: 18972276)
41. Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone.
Löfdahl CG; Ericsson A; Svensson K; Andreasson E
Pharmacoeconomics; 2005; 23(4):365-75. PubMed ID: 15853436
[TBL] [Abstract][Full Text] [Related]
42. [The influence of treatment with formoterol, formoterol with tiotropium, formoterol with inhaled glucocorticosteroid and tiotropium on lung functions, tolerance of exercise and simple, morning everyday activities in patients with chronic obstructive pulmonary disease (COPD)].
Szmidt M
Pneumonol Alergol Pol; 2012; 80(3):255-62. PubMed ID: 22562275
[TBL] [Abstract][Full Text] [Related]
43. Budesonide/formoterol pressurized metered-dose inhaler: in chronic obstructive pulmonary disease.
Lyseng-Williamson KA
Drugs; 2009 Jul; 69(11):1459-70. PubMed ID: 19634924
[TBL] [Abstract][Full Text] [Related]
44. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.
Tashkin DP; Hanania NA; McGinty J; Denis-Mize K; Chaudry I
Adv Ther; 2009 Nov; 26(11):1024-34. PubMed ID: 19953349
[TBL] [Abstract][Full Text] [Related]
45. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
Bölükbas S; Eberlein M; Eckhoff J; Schirren J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
[TBL] [Abstract][Full Text] [Related]
46. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
Ceylan E; Gencer M; Aksoy S
Respiration; 2004; 71(6):594-601. PubMed ID: 15627870
[TBL] [Abstract][Full Text] [Related]
47. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
Tashkin DP; Littner M; Andrews CP; Tomlinson L; Rinehart M; Denis-Mize K
Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
[TBL] [Abstract][Full Text] [Related]
48. Is there any difference between effects of ipratropium bromide and formoterol on exercise capacity in moderate COPD patients?
Akkoca Yildiz O; Onen ZP; Demir G; Eriş Gülbay B; Saryal S; Karabiyikoğlu G
Tuberk Toraks; 2006; 54(2):105-13. PubMed ID: 16924565
[TBL] [Abstract][Full Text] [Related]
49. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease.
Calverley PM; Boonsawat W; Cseke Z; Zhong N; Peterson S; Olsson H
Eur Respir J; 2003 Dec; 22(6):912-9. PubMed ID: 14680078
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation.
Santus P; Centanni S; Verga M; Di Marco F; Matera MG; Cazzola M
Respir Med; 2006 Jul; 100(7):1277-81. PubMed ID: 16337781
[TBL] [Abstract][Full Text] [Related]
51. Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma.
Sears MR; Boulet LP; Laviolette M; Fitzgerald JM; Bai TR; Kaplan A; Smiljanic-Georgijev N; Lee JS
Eur Respir J; 2008 May; 31(5):982-9. PubMed ID: 18216054
[TBL] [Abstract][Full Text] [Related]
52. Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease.
Centanni S; Di Marco F
Expert Opin Pharmacother; 2005 Nov; 6(14):2525-34. PubMed ID: 16259583
[TBL] [Abstract][Full Text] [Related]
53. Paradoxical trough effects of triple therapy with budesonide/formoterol and tiotropium bromide on pulmonary function outcomes in COPD.
Williamson PA; Short PM; Clearie KL; Vaidyanathan S; Fardon TC; Howaniec LJ; Lipworth BJ
Chest; 2010 Sep; 138(3):595-604. PubMed ID: 20418370
[TBL] [Abstract][Full Text] [Related]
54. The acute effect of budesonide/formoterol in COPD: a multi-slice computed tomography and lung function study.
De Backer LA; Vos W; De Backer J; Van Holsbeke C; Vinchurkar S; De Backer W
Eur Respir J; 2012 Aug; 40(2):298-305. PubMed ID: 22183484
[TBL] [Abstract][Full Text] [Related]
55. Comparative Efficacy of Budesonide/Formoterol with Budesonide, Formoterol or Placebo for Stable Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
Tang B; Wang J; Luo LL; Li QG; Huang D
Med Sci Monit; 2019 Feb; 25():1155-1163. PubMed ID: 30747109
[TBL] [Abstract][Full Text] [Related]
56. Rapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPD.
Cazzola M; Pasqua F; Ferri L; Biscione G; Cardaci V; Matera MG
Pulm Pharmacol Ther; 2011 Feb; 24(1):118-22. PubMed ID: 20816833
[TBL] [Abstract][Full Text] [Related]
57. Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.
Yasui H; Inui N; Furuhashi K; Nakamura Y; Uto T; Sato J; Yasuda K; Takehara Y; Suda T; Chida K
Pulm Pharmacol Ther; 2013 Jun; 26(3):336-41. PubMed ID: 23340058
[TBL] [Abstract][Full Text] [Related]
58. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.
Maltais F; Ostinelli J; Bourbeau J; Tonnel AB; Jacquemet N; Haddon J; Rouleau M; Boukhana M; Martinot JB; Duroux P
Am J Respir Crit Care Med; 2002 Mar; 165(5):698-703. PubMed ID: 11874817
[TBL] [Abstract][Full Text] [Related]
59. Evaluating the effectiveness of combination therapy to prevent COPD exacerbations: the value of NNT analysis.
Halpin DM
Int J Clin Pract; 2005 Oct; 59(10):1187-94. PubMed ID: 16178987
[TBL] [Abstract][Full Text] [Related]
60. Addition of inhaled corticosteroid on combined bronchodilator therapy in patients with COPD.
Basyigit I; Yildiz F; Ozkara SK; Yildirim E; Boyaci H; Ilgazli A
Pulm Pharmacol Ther; 2005; 18(6):422-6. PubMed ID: 15955716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
